Literature DB >> 10082107

High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent.

P Otal1, H Rousseau, J P Vinel, H Ducoin, S Hassissene, F Joffre.   

Abstract

PURPOSE: To assess whether the use of a prosthesis covered by a Dacron sheath might prevent pseudointimal hyperplasia in a transjugular intrahepatic portosystemic shunt (TIPS).
MATERIALS AND METHODS: A TIPS procedure was performed in nine pigs, after creation of a portal vein microembolization model of portal hypertension, by using a Dacron-covered nitinol stent. The first centimeter on the lower extremity of this specially made prototype was uncovered, to avoid portal vein thrombosis. Three weeks later, the seven surviving animals underwent transjugular hemodynamic and angiographic follow-up and were then killed for gross and histologic evaluation.
RESULTS: Shunt insertion was possible in all pigs; two died of complications of the procedure. After 3 weeks only two shunts were patent, although a 50%-60% narrowing of the initial portion of the shunt was present; the remaining shunts were occluded. Histologic examination showed pseudointimal hyperplasia associated, in the cases of occlusion, with a luminal thrombosis.
CONCLUSION: This Dacron-covered stent did not prevent pseudointima formation over the stent and resulted in a high early occlusion rate, probably related to a pronounced tissue fibrotic response likely due to Dacron-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082107     DOI: 10.1016/s1051-0443(99)70463-x

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

1.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

2.  Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts?

Authors:  Manfred Cejna
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

3.  Covered stents in transjugular portosystemic shunt: healing response to non-porous ePTFE covered stent grafts with and without intraluminal irradiation.

Authors:  Klaus A Hausegger; Horst Portugaller; Nicolas P Macri; Josef Tauss; Peter Schedlbauer; Johannes Deutschmann; Georg Stücklschweiger; Heidi Stranzl
Journal:  Eur Radiol       Date:  2002-10-31       Impact factor: 5.315

4.  Efficacy of a dexamethasone-eluting nitinol stent on the inhibition of pseudo-intimal hyperplasia in a transjugular intrahepatic portosystemic shunt: an experimental study in a swine model.

Authors:  Tae Seok Seo; Joo Hyeong Oh; Young Koo Park; Ho Young Song; Sang Joon Park; Sun Hong Yuk
Journal:  Korean J Radiol       Date:  2005 Oct-Dec       Impact factor: 3.500

Review 5.  The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.

Authors:  Fabrizio Fanelli
Journal:  ISRN Hepatol       Date:  2014-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.